Nurse Practitioner, Family · Hobart, IN
NPI
1063042513
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
174 Bracken Pkwy
Hobart, IN, 46342
Phone (219) 227-5119
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
386 services
Medicare patients, 2024
143
Average age 70
Drug cost, 2024
$2.0M
2,416 prescriptions
Company payments, 2025
$3,620
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jillian R Greer was code 99213 (office e&m - established), 133 times for 76 patients. In total Jillian R Greer billed 386 services in 15 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 133 | 76 | $49.44 | $6,575 |
| 99214 Office E&M - Established | Office | 120 | 74 | $70.37 | $8,444 |
| 83036 Blood Count | Office | 45 | 30 | $8.67 | $390 |
| 99204 Office E&M - New | Office | 23 | 23 | $85.65 | $1,970 |
| 95251 Test - Miscellaneous | Office | 22 | 13 | $20.86 | $459 |
| 99215 Office E&M - Established | Office | 12 | 11 | $113.11 | $1,357 |
By year: 2022 $19K for 353 services; 2023 $20K for 375 services; 2024 $22K for 386 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 45 | 30 | $8.67 | $390 |
Medicare prescription drug claims, 2024
In 2024, the drug Jillian R Greer prescribed most often to Medicare patients was Levothyroxine Sodium, with 307 prescriptions and refills. In total Jillian R Greer wrote 2,416 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 307 | 729 | 96 | $2,985 |
| Ozempic Semaglutide | 206 | 408 | 75 | $389K |
| Mounjaro Tirzepatide | 158 | 234 | 43 | $249K |
| Jardiance Empagliflozin | 130 | 285 | 41 | $164K |
| Synthroid Levothyroxine Sodium | 113 | 260 | 33 | $11K |
| Metformin Hcl Generic | 98 | 244 | 36 | $673 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 90 | 196 | 32 | $18K |
| Liothyronine Sodium Generic | 85 | 201 | 32 | $3,901 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 69 | 179 | 34 | $8,881 |
| Unithroid Levothyroxine Sodium | 63 | 142 | 21 | $1,660 |
| Metformin Hcl Er Metformin Hcl | 48 | 130 | 17 | $246 |
| Tresiba Flextouch U-200 Insulin Degludec | 44 | 104 | 11 | $84K |
| Farxiga Dapagliflozin Propanediol | 43 | 111 | 18 | $61K |
| Topiramate Generic | 34 | 89 | 15 | $151 |
| Ezetimibe Generic | 32 | 92 | 11 | $393 |
Brand drugs: 1,316 claims; generic drugs: 981 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jillian R Greer $3,620 ($3,620 in general payments such as food, travel and fees) from 23 companies. The largest payer was Recordati_rare_diseases_inc. with $482.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 34 | $482 |
| Ascensia Diabetes Care Us Inc. | 20 | $329 |
| Amneal Pharmaceuticals LLC AMRX | 20 | $312 |
| Abbvie Inc. ABBV | 15 | $285 |
| Medtronic, Inc. MDT | 7 | $282 |
| Madrigal Pharmaceuticals MDGL | 8 | $280 |
| Lilly USA, LLC LLY | 16 | $279 |
| Novo Nordisk Inc NVO | 16 | $237 |
| Amgen Inc. AMGN | 12 | $218 |
| Xeris Pharmaceuticals, Inc. | 17 | $212 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.